SCHEMBL9111095

SCHEMBL9111095

[CH2]C=CCCCC1CNCCN1

nearest known ligand 0.39

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9113903 0.89 CXCR4 (0.34) CXCR4
SCHEMBL5548332 0.78 CXCR4 (0.41) CXCR4
SCHEMBL9110599 0.77 LTA4H (0.31)
SCHEMBL293194 0.75 CXCR4 (0.44) CXCR4
SCHEMBL1270118 0.73 CXCR4 (0.42) CXCR4
SCHEMBL9111833 0.73 CXCR4 (0.33) CXCR4
SCHEMBL7297443 0.73 CXCR4 (0.40) CXCR4
SCHEMBL55509 0.72 CXCR4 (0.41) CXCR4
SCHEMBL5542007 0.71 CXCR4 (0.39) CXCR4
SCHEMBL6224046 0.71 CXCR4 (0.44) CXCR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0670831-A1 QUINOXALINE DERIVATIVE AS ANTIDIABETIC AGENT OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1995-09-13 EP disclosed
WO-1995009159-A1 QUINOXALINE DERIVATIVE AS ANTIDIABETIC AGENT OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1995-04-06 WO disclosed